530313
KIMIABL
Start SIP
Invest Now
Start SIP in KIMIABL
Performance
- Low
- ₹32
- High
- ₹33
- 52 Week Low
- ₹26
- 52 Week High
- ₹87
- Open Price₹33
- Previous Close₹33
- Volume1,506
Investment Returns
- Over 1 Month + 9.16%
- Over 3 Month -6.93%
- Over 6 Month -29.26%
- Over 1 Year -32.95%
Smart Investing Starts Here Start SIP with Kimia Biosciences for Steady Growth!
Kimia Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19
- PEG Ratio
- 0.1
- Market Cap Cr
- 156
- P/B Ratio
- Average True Range
- 2.68
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.9
- RSI
- 55.15
- MFI
- 19.96
Kimia Biosciences Financials
Kimia Biosciences Technicals
EMA & SMA
Current Price
₹32.90
+
0.3
(0.92%)
- Bearish Moving Average 6
- Bullish Moving Average 10
- 20 Day
- ₹31.05
- 50 Day
- ₹33.14
- 100 Day
- ₹37.08
- 200 Day
- ₹41.11
Resistance and Support
32.47
- R3 34.63
- R2 33.85
- R1 33.25
- S1 31.87
- S2 31.09
- S3 30.49
Kimia Biosciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-09-04 | Final Dividend & A.G.M. | |
| 2025-08-29 | A.G.M. & Others | Inter-alia, to consider 1. Appointment of Neeraj Arora & Associates, Chartered Accountants as Statutory Auditors for 5 years. 2. Re-appointment of Mr. Sameer Goel. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-05-26 | Audited Results |
Kimia Biosciences F&O
About Kimia Biosciences
- NSE Symbol
- KIMIABL
- BSE Symbol
- 530313
- Chairman & Managing Director
- Mr. Sameer Goel
- ISIN
- INE285U01025
Similar Stocks to Kimia Biosciences
Kimia Biosciences FAQs
Kimia Biosciences share price is ₹32 As on 12 December, 2025 | 20:45
The Market Cap of Kimia Biosciences is ₹155.7 Cr As on 12 December, 2025 | 20:45
The P/E ratio of Kimia Biosciences is 19 As on 12 December, 2025 | 20:45
The PB ratio of Kimia Biosciences is 15.6 As on 12 December, 2025 | 20:45
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.